Connection

Amarendra Neppalli to Clinical Trials, Phase I as Topic

Back to Details
This is a "connection" page, showing publications Amarendra Neppalli has written about Clinical Trials, Phase I as Topic.
Amarendra Neppalli
Connection Strength
0.047
Clinical Trials, Phase I as Topic
  1. Comparison of Cilta-cel, an Anti-BCMA CAR-T Cell Therapy, Versus Conventional Treatment in Patients With Relapsed/Refractory Multiple Myeloma. Clin Lymphoma Myeloma Leuk. 2022 05; 22(5):326-335.
    View in: PubMed
    Score: 0.047
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.